Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kane Biotech Inc. Proxy Solicitation & Information Statement 2018

Mar 16, 2018

45287_rns_2018-03-16_0591de7b-cdb3-4090-bbb0-d6ec3c856b90.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

March 16, 2018

Alberta Securities Commission Manitoba Securities Commission TSX Venture

Saskatchewan Financial and Consumer Affairs Authority British Columbia Securities Commission

RE: Kane Biotech Inc.

Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual and Special Meeting of Shareholders:

Date of meeting: May 17, 2018
Record date for notice: April 12, 2018
Record date for voting: April 12, 2018
Beneficial ownership determination date: April 12, 2018

Date of meeting: May 17, 2018
Record date for notice: April 12, 2018
Record date for voting: April 12, 2018
Beneficial ownership determination date: April 12, 2018
Securities entitled to notice: Common
Securities entitled to vote: Common
Issuer mailing directly to non-objecting beneficial owners: No
Issuer will pay for objecting beneficial owner material distribution: Yes
Issuer using notice-and-access for registered investors: No
Issuer using notice-and-access for non-registered investors: No
Notice-and-access stratification criteria: No
Sincerely,

Securities entitled to notice: Common
Securities entitled to vote: Common
Issuer mailing directly to non-objecting beneficial owners: No
Issuer will pay for objecting beneficial owner material distribution: Yes
Issuer using notice-and-access for registered investors: No

Issuer using notice-and-access for non-registered investors: No
Notice-and-access stratification criteria: No
Sincerely,

Maria Khan Associate Manager, Trust Central Services